Clinical trials
Phase 3 Diabetic Nephropathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 4 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Alessandro Doria | 2 |
| Bayer | 2 |
| Geisinger Clinic | 1 |
| Janssen Research & Development, LLC | 1 |
| Joslin Diabetes Center | 1 |
| Keryx Biopharmaceuticals | 1 |
| NephroGenex, Inc. | 1 |
| Speedel Pharma Ltd. | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 14 |
| Diabetes Mellitus, Type 2 | 7 |
| Kidney Diseases | 4 |
| Kidney Failure, Chronic | 3 |
| Renal Insufficiency, Chronic | 3 |
| Diabetes Mellitus | 2 |
| Albuminuria | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Complications | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.